Form D · Biotechnology
Ocean Biomedical, Inc.
Providence, RI · CIK 0001836612
Offering snapshot reported Apr 12, 2021 · SEC filing
- Reported sold
- $1.04M Indefinite offering
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 12, 2021 | Initial | $1,044,657 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-395399
Source: Form D, filed Apr 12, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jonathan Heller | Executive |
| Gurinder Kalra | Executive |
| Chirinjeev Kathuria, | Director, Executive |
| Elizabeth Ng | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
55 Claverick Street Room 325
Providence, RI, 02903
Providence, RI, 02903